DIRS.INFO The most relevant business & tech news

☆ Moo Deng: Baby pygmy hippo is Thailand’s latest online sensation. But her keeper is worried about her fame
▼ + stars: | 2024-09-14 | by ( Kocha Olarn | Chris Lau | ) edition.cnn.com time to read: +3 min

Moo Deng gives her handler a good chew on the knee. One person poured water [on her] while another threw a shell onto Moo Deng when she lay on the floor,” he said. While she continues to draw admirers in person, Moo Deng has found her biggest stardom online. “This will be the time Moo Deng will be energetic as the keeper will splash the water around,” he said. Another good time would be in the afternoon when the keeper feeds her mother, as Moo Deng follows her around.

Persons: Deng, she’s, ” Narongwit Chodchoy, Moo Deng, Narongwit, Moo, ”, –, Aom, Napatsawan Balee, “ Haha, Jona, Tony Organizations: Bangkok CNN —, CNN, Facebook Locations: Bangkok, Thai, West Africa, Liberia, Sierra Leone, Guinea, Ivory Coast, Jona

☆ Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
▼ + stars: | 2023-10-23 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +3 min

Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. Last month, the firm made a case for there being a $150 billion to $200 billion opportunity for these drugs. At the moment, private insurance coverage isn't a guarantee for those seeking weight loss treatment, and the federal Medicare program doesn't cover weight loss drugs at all. Lilly expects the Food and Drug Administration to approve this drug to treat obesity by the end of this year.

Persons: Seamus, Fernandez, Andrew Baum, Goldman Sachs, Chris Shibutani, Shibutani, Eli Lilly, Lilly Organizations: Monday, Citi, Wegovy, Food and Drug Administration Locations: GLP

☆ The risks to alcohol and food stocks from Ozempic-like weight loss drugs
▼ + stars: | 2023-09-20 | by ( Paulina Likos | ) www.cnbc.com time to read: +9 min

The rise of new anti-obesity medications could result in less alcohol consumption, impacting Club name Constellation Brands (STZ). The risk already seems to be playing out in food stocks with exposure to snacks and junk food. We don't think Constellation Brands stock will suffer the same fate as shares of leading snack food companies like J.M. Key points The increasing popularity of new diabetes/weight loss drugs could curtail consumer appetite for junk food and alcohol. Constellation Brands (STZ), the Club name behind the Mexican beers Corona and Modelo, should be able to weather any such headwind.

Persons: Eli Lilly, it's, Mills, Lilly, Jim Cramer, Mounjaro, Morgan, Morgan Stanley, AOMs, Jefferies, Jim Cramer's, Jim, Gabby Jones Organizations: Constellation Brands, Corona, Modelo, Pacifico, Nordisk, Ozempic, Club, Novo Nordisk, Brands, Conagra Brands, Constellation, Bud Light, Jefferies, JPMorgan, CNBC, Bloomberg, Getty Locations: U.S, Oro, Brooklyn Borough, New York

☆ Here are the 5 things you should do when you get a bad performance review and your boss isn't in your corner
▼ + stars: | 2022-11-30 | by ( Rebecca Knight | ) www.businessinsider.com time to read: +6 min

Insider spoke with career experts about the steps you should take after you get a bad review. "But if your manager isn't in your corner — isn't aligned with you and isn't trying to help you advance — it can be really stressful and deflating." Insider spoke with Elias and other career experts about the five steps you should take after you get a bad review. A line-by-line rebuttal isn't wise, but Layfield said that some well-reasoned (and polite) counterarguments that debunk or weaken your boss' assessment might be warranted. "Look for things that are within your control that your boss can't take away from you," she said.

Search resuls for: "Aom"

4 mentions found